- Home
- TSHA vs MACI Comparison
TSHA vs MACI Comparison
Compare TSHA & MACI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- MACI
- Stock Information
- Founded
- TSHA 2019
- MACI 2024
- Country
- TSHA United States
- MACI United States
- Employees
- TSHA N/A
- MACI N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- MACI
- Sector
- TSHA Health Care
- MACI
- Exchange
- TSHA Nasdaq
- MACI NYSE
- Market Cap
- TSHA 262.4M
- MACI 221.6M
- IPO Year
- TSHA 2020
- MACI 2024
- Fundamental
- Price
- TSHA $1.24
- MACI $10.28
- Analyst Decision
- TSHA Strong Buy
- MACI
- Analyst Count
- TSHA 8
- MACI 0
- Target Price
- TSHA $6.63
- MACI N/A
- AVG Volume (30 Days)
- TSHA 2.4M
- MACI 15.0K
- Earning Date
- TSHA 05-13-2025
- MACI 01-01-0001
- Dividend Yield
- TSHA N/A
- MACI N/A
- EPS Growth
- TSHA N/A
- MACI N/A
- EPS
- TSHA N/A
- MACI N/A
- Revenue
- TSHA $8,333,000.00
- MACI N/A
- Revenue This Year
- TSHA N/A
- MACI N/A
- Revenue Next Year
- TSHA N/A
- MACI N/A
- P/E Ratio
- TSHA N/A
- MACI $44.00
- Revenue Growth
- TSHA N/A
- MACI N/A
- 52 Week Low
- TSHA $1.05
- MACI $9.95
- 52 Week High
- TSHA $4.32
- MACI $10.35
- Technical
- Relative Strength Index (RSI)
- TSHA 40.35
- MACI N/A
- Support Level
- TSHA $1.05
- MACI N/A
- Resistance Level
- TSHA $1.36
- MACI N/A
- Average True Range (ATR)
- TSHA 0.17
- MACI 0.00
- MACD
- TSHA -0.01
- MACI 0.00
- Stochastic Oscillator
- TSHA 25.68
- MACI 0.00
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About MACI MELAR ACQUISITION CORP. I
Melar Acquisition Corp I is a blank check company.